Quarterly report pursuant to Section 13 or 15(d)

Share Purchase Options

Share Purchase Options
9 Months Ended
May 31, 2019
Share-based Payment Arrangement [Abstract]  

(a) Stock option plan

The Company has a stock option plan which allows the Board of Directors of the Company to grant options to acquire common shares of the Company to directors, officers, key employees and consultants. The option price, term and vesting are determined at the discretion of the Board of Directors, subject to certain restrictions as required by the policies of the TSX Venture Exchange. The stock option plan is a 20% fixed number plan with a maximum of 17,969,849 common shares reserved for issuance.

During the three and nine months ended May 31, 2019, no share options were granted. During the year ended August 31, 2018 the Company granted 9,775,000 share options to directors, officers and consultants of the Company. The weighted average fair value of the options granted was estimated at $0.87 per share at the grant date using the Black-Scholes option pricing model.

On December 31, 2018, options to acquire 50,000 shares of common stock, at an exercise price of CAD$4.80 expired, unexercised.

  (b) Share purchase options

Share purchase option transactions under the stock option plan were:

Share purchase options outstanding and exercisable as at May 31, 2019 are:

Expiry Date   Exercise






February 1, 2026   CAD $5.85     33,333       33,333  
November 30, 2027   CAD $2.27     1,425,000       1,425,000  
June 5, 2028   CAD $1.00     8,350,000       3,400,000  
          9,808,333       4,858,333  
Weighted average remaining contractual life         8.9 years       8.9 years  
Weighted average exercise price         CAD $1.20      

CAD $1.41